AstraZeneca Nabs $750 Million In New Coronavirus Vaccine Funding

AstraZeneca Nabs $750 Million In New Coronavirus Vaccine Funding

UK-based drug company AstraZeneca can now produce 2 billion doses of its coronavirus vaccine after receiving $750 million in additional funding — but AZN stock pared earlier gains.